Dr. Liat Hogen
Inclusion Criteria:
- Patients treated at Fondazione Policlinico Gemelli Hospital, Rome Italy, Trillium
-Credit Valley Hospital, Mississauga, Ontario and Princess Margaret Cancer Centre,
Toronto, Canada
- Patients fit for cytoreductive surgery
- Patients with a primary diagnosis of suspect Stage III-IV ovarian cancer
- Patients selected for interval cytoreductive surgery after NACT
Exclusion Criteria:
- Patients with pre-operative Stage I-II disease confined to the pelvis
- Patients unfit for surgery
- Lack of information about patients' surgical outcomes and clinicopathological
characteristics
- LGSOC, Clear cell and mucinous, non-epithelial histologic subtypes (if available)